ScholarIQanswers from OpenAlex

Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study

PaperCitations, authors & open-access status

Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study have?

ScholarIQcitation count

Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study has 9 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study published?

ScholarIQyear

Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study has 2025 year in the ScholarIQ index.

What is the open-access status of Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study?

ScholarIQoa status

Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study has gold oa status in the ScholarIQ index.

What is the DOI of Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study?

ScholarIQdoi

The DOI for Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study is on the source record.

What is the PMID of Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study?

ScholarIQpmid

The PMID for Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study is on the source record.

What is the OpenAlex record for Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study?

ScholarIQopenalex

The OpenAlex for Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial